Business and News Update - Applied Clinical Trials

ADVERTISEMENT

See our 2012 Buyers Guide Digital Edition.
Find Pharma Search Engine
Business and News Update

Source: Applied Clinical Trials


People

• DAC Patient Recruitment Services (Dallas, TX) announced that Diana Anderson, PhD, will transition from her role as President to that of Patient Recruitment Consultant to the company she founded 20 years ago.


Joseph A. Pierro, MD
• Biomedical Systems,(St. Louis, MO) a global provider of digital medical imaging technologies and centralized diagnostic services, has named Joseph A. Pierro, MD, its chief medical officer for Biomedical's North American operations. In his role, Pierro and his team will advise clients on their clinical trial protocols, supporting studies conducted in the fields of cardiology, oncology, imaging, and pulmonology.

• Chiltern International Limited, (London, UK) a global contract research organization, announced that Dieter Seitz-Tutter, PhD, and Alexandra Adams, PhD, have joined Chiltern.


Yvonne Higgins
• Copernicus Group IRB, (Research Triangle Park, NC) an independent institutional review board, announced the promotion of Yvonne Higgins to Vice President, Quality Management. In addition to her promotion, Higgins has been appointed as CGIRB's Institutional Official.

• ICON plc, (Dublin, Ireland) a global provider of outsourced development services to pharmaceutical, biotechnology, and medical device industries, announced leadership appointments to its Asia Pacific and Latin American teams. Wei Ming Goh has been appointed Vice President, Asia Pacific, and Dennis Hurley, PhD, has been appointed Vice President, Latin America.

• RadSite, (Houston, TX) certification and accreditation agency for imaging quality, announced two new additions. Eliot Siegel, MD, has joined the team as Chief Quality Officer. Siegel will help oversee and promote the integrity of all quality-based programs and research initiatives for RadSite. Bruce Reiner, MD, a board certified radiologist, has also joined the team as Director of Accreditation. Reiner will help ensure RadSite's quality-benchmarking program conforms to current best practice standards.

• Chiltern International Limited, (London, UK) announced a succession of Chief Executive Officer, with Glenn Kerkhof stepping down and Jim Esinhart, PhD appointed.

• PharmaNet/i3, (Princeton, NJ) inVentiv Health's clinical segment, announced that Jamil Hantash, MSc, MBA, has joined the company as the Director of Immunochemistry Operations at the Princeton bioanalytical laboratory.


ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

Access Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA | July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA | August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA | August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA | August 20-21, 2013
Request Brochure

See All Conferences >>

FindPharma
Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
94%
Borrow lightly from EMA's pathway program?
0%
Create entirely its own pathway program?
6%
View Results
Untitled Document
Source: Applied Clinical Trials,
Click here